Nesvacumab Biosimilar - Research Grade [ICH5010]
Catalogue Number: ICH5010-ICB
| Manufacturer: | IchorBio |
| Type: | Recombinant Monoclonal |
| Alias: | ANGPT2, ANG2 |
| Shipping Condition: | Blue Ice |
| Unit(s): | 10 mg, 20 mg, 5 mg, 50 mg, 1 mg, 100 mg |
| Host name: | |
| Clone: | |
| Isotype: | IgG1 |
| Immunogen: | |
| Application: | FA |
Description
Description: RUO nesvacumab is an experimental monoclonal antibody originally designed for the treatment of cancer. It targets the protein angiopoietin 2. As of May 2017, it is in Phase II clinical trials for the treatment of diabetic macular edema.
Additional Text
Uniprot ID
O15123
Gene Name
ANGPT2
Gene ID
285
Concentration
5 mg/ml
Purification
Protein A/G Purified
Antibody Clonality
Recombinant Monoclonal
Application Notes
This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.
Storage Note
This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.
ICH5010 Datasheet
SUPPORT
outstanding technical support
PRODUCT
we offer a full product guarantee
DELIVERY
we offer free delivery to UK universities and non profit organisations